title: Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
abstract: The effect of Moloney murine leukemia virus (MoMLV) infection was examined in mice lacking a functional p53 gene. Virus-infected p53-/- mice developed tumors significantly faster than uninfected p53-/- or virus-infected p53+/+ littermates. However, the degree of synergy between MoMLV and the p53 null genotype was weaker than the synergy between either of these and c-myc transgenes. A similar range of T-cell tumor phenotypes was represented in all p53 genotype groups, including p53-/- mice, which developed thymic lymphomas as the most common of several neoplastic diseases. Lack of p53 was associated with higher rates of metastasis and the ready establishment of tumors in tissue culture. Loss of the wild-type allele was a common feature of tumors in p53+/- mice and was complete in tumor cells in vitro, but this appeared to occur by a mechanism other than proviral insertion at the wild-type allele. A lower average MoMLV proviral copy number was observed in tumors of the p53 null and heterozygote groups, suggesting that the absence of a functional p53 gene reduced the number of steps required to complete the malignant phenotype. Mink cell focus-forming virus-like proviruses were detected in tumors of all infected mice but were relatively rare in p53 null mice. Analysis of c-myc, pim-1, and pal-1 showed that these loci were occupied by proviruses in some cases but at similar frequencies in p53 wild-type and null mice. In conclusion, while inactivation of p53 in the germ line predisposes mice to tumors similar in phenotype to those induced by MoMLV, it appears that virus-induced tumors generally occur without p53 loss. We speculate that a bcl-2-like function carried or induced by MoMLV may underlie this p53-independent pathway.
authors.affiliation: Department of Veterinary Pathology, University of Glasgow, Bearsden, United Kingdom.
authors.forename: E W
authors.initials: EW
authors.lastname: Baxter
authors.forename: K
authors.initials: K
authors.lastname: Blyth
authors.forename: L A
authors.initials: LA
authors.lastname: Donehower
authors.forename: E R
authors.initials: ER
authors.lastname: Cameron
authors.forename: D E
authors.initials: DE
authors.lastname: Onions
authors.forename: J C
authors.initials: JC
authors.lastname: Neil
mesh_terms: D000483:Alleles; D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D005787:Gene Frequency; D015321:Gene Rearrangement; D016259:Genes, myc; D018740:Genetic Heterogeneity; D005838:Genotype; D008223:Lymphoma / Q000235:genetics / Q000821:virology*; D051379:Mice; D008822:Mice, Transgenic; D008908:Mink Cell Focus-Inducing Viruses; D008969:Molecular Sequence Data; D008979:Moloney murine leukemia virus / Q000235:genetics / Q000502:physiology*; D016254:Mutagenesis, Insertional; D010641:Phenotype; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins / Q000235:genetics; D051573:Proto-Oncogene Proteins c-pim-1; D011533:Proviruses; D012192:Retroviridae Infections / Q000235:genetics / Q000821:virology*; D013953:Thymus Neoplasms / Q000235:genetics / Q000821:virology*; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D014412:Tumor Virus Infections / Q000235:genetics / Q000821:virology*
chemical_list: D017931:DNA Primers; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53; C496636:Pim1 protein, mouse; D017346:Protein Serine-Threonine Kinases; D051573:Proto-Oncogene Proteins c-pim-1